Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SIBP-A16
- Development stage
- Phase 2
- Lead developer
- Shanghai Institute of Biological Products
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intramuscular, Intravenous
01
Overview
SIBP-A16 is a **monoclonal antibody** developed for the prevention of lower respiratory tract infections caused by **respiratory syncytial virus (RSV)**. Its mechanism of action involves inhibition of the **RSV F (fusion) protein**, blocking viral entry into host cells and consequently preventing infection. It is intended as a specific immunopreventive therapy for RSV, particularly in infants and young children. The drug is developed by the Shanghai Institute of Biological Products, a subsidiary of Sinopharm's China National Biotec Group, and represents a notable advance in China's bioprophylactic antibody research and development system[1][3][7][10].
- Brand names
- SIBP-A16SIBP-A-16SIBP-A 16
- Other names
- SIBP-A16SIBP-A-16SIBP-A 16
02
Targets
RSV F (Respiratory syncytial virus fusion protein)
Beyond the preview
Go deeper on SIBP-A16.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SIBP-A16.